Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?

ABSTRACT:

SUBMITTER: Lo Muzio L 

PROVIDER: S-EPMC9107288 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature